Zifanocycline

吡普环素

Report date: 2023/07/28 18:09:08
NMEQIDP

Base Information

Drug NameZifanocycline
Drug Alias NameBipyrocyclinezifanociclinaKBP-7072
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of Action30S ribosomal subunit inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShandong Hengli Pharmaceutical Technology Co LtdKbp Biosciences Usa
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesKbp BiosciencesShandong Hengli Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A